CIK 0001837607 · <br>Emerging growth company
AEON Biopharma, Inc.
Sign in to watch- Ticker
- AEON
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853940478
- Phone
- (949) 354-6499
- Business address
- 130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
- Former names
- Priveterra Acquisition Corp.
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS/A Other ARS/A
- DEFA14A Proxy Proxy Materials
- 10-K/A Report 10-K/A
- 8-K Event Restatement
- 8-K Event Regulation FD disclosure · Other events
- UPLOAD Other SEC-generated Letter
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 25-NSE Other Notification of Removal from Listing
- 3 Insider Initial Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · New debt or obligation · Executive or director change
- 4/A Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure
Page 9 of 19 · 363 filings